Ticker Details
Sight Sciences, Inc. Common Stock
IPO Date:	July 12, 2021
Sector:	Healthcare
Industry:	Medical Devices
Market Cap:	$285.51M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.31 | 3.55%
Avg Daily Range (30 D):	$0.15 | 2.44%
Avg Daily Range (90 D):	$0.21 | 3.17%

Institutional Daily Volume
Avg Daily Volume:	.21M
Avg Daily Volume (30 D):	.21M
Avg Daily Volume (90 D):	.22M

Trade Size
Avg Trade Size (Sh.):	82
Avg Trade Size (Sh.) (30 D):	65
Avg Trade Size (Sh.) (90 D):	73

Institutional Trades
Total Institutional Trades:	127
Avg Institutional Trade:	$2.29M
Avg Institutional Trade (30 D):	$3.24M
Avg Institutional Trade (90 D):	$1.22M
Avg Institutional Trade Volume:	.18M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$3.4M
Avg Closing Trade (30 D):	$3.24M
Avg Closing Trade (90 D):	$1.39M
Avg Closing Volume:	258.03K

News

Sep 9, 2025 @ 3:39 PM UnitedHealthcare Adds Sight Sciences OMNI System T... Source: Vandana Singh

Jul 30, 2025 @ 11:00 AM Sight Sciences Announces the Results of a Cost-Uti... Source: Nathan Lighthizer Et Al.

Jul 29, 2025 @ 11:00 AM Sight Sciences Announces the Publication of the 24... Source: Sight Sciences, Inc.

Feb 10, 2025 @ 3:00 PM Dry Eye Treatment Devices Market Poised to Attain ... Source: Astute Analytica

Jul 18, 2024 @ 8:06 PM Sight Sciences to Report Second Quarter Financial ... Source: N/A

Financials
	TTM	Q2 2025	Q1 2025
Basic EPS	$-.16	$-.23	$-.28
Diluted EPS	$-.16	$-.23	$-.28
Revenue	$19.91M	$19.56M	$17.51M
Gross Profit	$17.2M	$16.59M	$15.09M
Net Income / Loss	$-8.17M	$-11.94M	$-14.15M
Operating Income / Loss	$-7.91M	$-11.67M	$-13.86M
Cost of Revenue	$2.71M	$2.98M	$2.41M
Net Cash Flow	$-8.86M	$-18.86M	$M
PE Ratio